Danske Bank A/S
Danske Bank share buy-back programme: transactions in week 18
Danske Bank share buy-back programme: transactions in week 18
| Company announcement no. 23 2025 Danske Bank Bernstorffsgade 40 DK-1577 København V Tel. + 45 33 44 00 00 05 May 2025 Page 1 of 1 Danske Bank share buy-back programme: transactions in week 18 On 7 February 2025, Danske Bank A/S announced a share buy-back programme for a total of DKK 5 billion, with a maximum of 45,000,000 shares, in the period from 10 February 2025 to 30 January 2026, at the latest, as described in company announcement no. 6 2025. The Programme is carried out in accordance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and Council of 16 April 2014 (the "Market Abuse Regulation") and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (together with the Market Abuse Regulation, the "Safe Harbour Rules"). The following transactions on Nasdaq Copenhagen A/S were made under the share buy-back programme in week 18: |
| Number of shares | VWAP DKK | Gross value DKK | |
| Accumulated, last announcement | 3,988,879 | 220.8030 | 880,756,453 |
| 28 April 2025 | 153,145 | 223.7029 | 34,258,981 |
| 29 April 2025 | 450,000 | 227.2175 | 102,247,875 |
| 30 April 2025 | 406,167 | 229.0336 | 93,025,890 |
| 01 May 2025 | 179,271 | 230.2048 | 41,269,045 |
| 02 May 2025 | 345,113 | 239.6084 | 82,691,974 |
| Total accumulated over week 18 | 1,533,696 | 230.4849 | 353,493,764 |
| Total accumulated during the share buyback programme | 5,522,575 | 223.4918 | 1,234,250,217 |
With the transactions stated above, the total accumulated number of own shares under the share buy-back programme corresponds to 0.661% of Danske Bank A/S' share capital. Danske Bank Contact: Claus Ingar Jensen, Head of Group Investor Relations, tel. +45 25 42 43 70 |
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
BioAegis Therapeutics7.5.2025 03:48:13 CEST | Press release
BioAegis Therapeutics Announces Site Activation and Patient Recruitment Underway in 13 Countries in Phase 2b Clinical Trial of Gelsolin, an Immune Regulator, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)
Tenaris SA7.5.2025 00:25:22 CEST | Press release
Shareholders approve all resolutions on the agendas of Tenaris’s Annual General Meeting and Extraordinary General Meeting of Shareholders
Calibre Mining Corp.6.5.2025 23:00:26 CEST | Press release
Calibre Receives Court Approval for Arrangement with Equinox Gold
nCino, Inc.6.5.2025 22:35:00 CEST | Press release
nCino to Host 2025 Investor Day
Atico Mining Corporation6.5.2025 22:30:00 CEST | Press release
Atico Produces 2.23 Million Pounds of Cu and 1,553 Ounces of Au in First Quarter 2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom